Citigroup »

Atara Biotherapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.2k 14k 0.51
2023-09-30 $670k 453k 1.48
2023-03-31 $2.6M 911k 2.90
2022-12-31 $3.4M 1.0M 3.28
2022-09-30 $5.1M 1.3M 3.94
2021-12-31 $16M 1.0M 15.76
2021-03-31 $6.1M 428k 14.36
2020-12-31 $25M 1.3M 19.63
2020-09-30 $2.3M 175k 12.96
2020-06-30 $3.3M 225k 14.57
2020-03-31 $1.8M 215k 8.50
2019-12-31 $3.0M 182k 16.47
2019-09-30 $2.1M 151k 14.12
2019-06-30 $1.4M 69k 20.11
2019-03-31 $602k 15k 39.74
2018-12-31 $3.9M 112k 34.89
2018-09-30 $3.5M 84k 41.34
2018-06-30 $2.0M 56k 36.73
2018-03-31 $2.3M 60k 39.03
2017-12-31 $4.0k 229 17.47
2017-09-30 $1.0k 80 12.50
2017-06-30 $2.0k 169 11.83
2017-03-31 $5.0k 239 20.92
2016-12-31 $627k 44k 14.19
2016-09-30 $47k 2.2k 21.39
2016-06-30 $135k 6.0k 22.55
2015-12-31 $0 1.6k 0.00
2015-09-30 $496k 16k 31.42
2015-06-30 $9.5k 266 35.71